| __timestamp | ACADIA Pharmaceuticals Inc. | CRISPR Therapeutics AG |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 1513000 |
| Thursday, January 1, 2015 | 73869000 | 12573000 |
| Friday, January 1, 2016 | 99284000 | 42238000 |
| Sunday, January 1, 2017 | 149189000 | 69800000 |
| Monday, January 1, 2018 | 187163000 | 113773000 |
| Tuesday, January 1, 2019 | 240385000 | 179362000 |
| Wednesday, January 1, 2020 | 319130000 | 266946000 |
| Friday, January 1, 2021 | 239415000 | 438633000 |
| Saturday, January 1, 2022 | 361575000 | 461645000 |
| Sunday, January 1, 2023 | 351619000 | 387332000 |
| Monday, January 1, 2024 | 320653000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, CRISPR Therapeutics AG and ACADIA Pharmaceuticals Inc. have been at the forefront of this race.
From 2014 to 2023, ACADIA Pharmaceuticals Inc. increased its R&D spending by nearly 480%, starting from a modest $60 million in 2014 to a peak of $362 million in 2022. Meanwhile, CRISPR Therapeutics AG, a pioneer in gene editing, saw an astronomical rise in its R&D budget, growing from just over $1 million in 2014 to a staggering $462 million in 2022, marking an increase of over 30,000%.
These investments underscore the companies' dedication to advancing medical science. As we look to the future, the continued growth in R&D spending will likely drive groundbreaking innovations in the biotech industry.
argenx SE or CRISPR Therapeutics AG: Who Invests More in Innovation?
Comparing Innovation Spending: argenx SE and ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Viatris Inc. and CRISPR Therapeutics AG
BioMarin Pharmaceutical Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
R&D Insights: How Jazz Pharmaceuticals plc and ACADIA Pharmaceuticals Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and CRISPR Therapeutics AG
Analyzing R&D Budgets: Axsome Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
R&D Insights: How CymaBay Therapeutics, Inc. and ACADIA Pharmaceuticals Inc. Allocate Funds
CRISPR Therapeutics AG vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: CRISPR Therapeutics AG and Evotec SE
Research and Development: Comparing Key Metrics for Veracyte, Inc. and ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: ACADIA Pharmaceuticals Inc. vs Xencor, Inc.